Myosana Therapeutics
Project Details
Myosana Therapeutics, Inc. is pioneering efforts in developing non-viral targeted gene therapy for skeletal muscle and cardiac diseases. Their current focus is Duchenne muscular dystrophy (DMD) but their platform applies to any genetic muscle disease.
Myosana Therapeutics wanted a website prioritizing both clear descriptions of their work about gene therapy in neuromuscular diseases and a design focusing on user-friendly navigation and overall visual appeal that they could easily maintain on their own.
Thomas Digital created a custom WordPress website for Myosana Therapeutics to better connect with its target audience. The site features up-to-date news and research data.